Abstract
Purpose of review: Review of the drug Rebamipide, an ophthalmic suspension, in the treatment of dry eye and other ocular surface disorders. Method: An extensive literature search was done on articles published in various ophthalmic journals to review the work on the latest drug rebamipide and its role in treating dry eye and other ocular surface disorders. Recent Findings: Rebamipide is a novel drug for the treatment of dry eye disorders. It is a mucin-secretogogue, has a cytoprotective, anti-inflammatory effect and also suppresses the detrimental oxygen free radicals and helps in faster healing of epithelium. No major side effect has been noticed apart from dysguesia. Summary: Rebamipide is the latest drug introduced in the treatment of dry eye. It seems to be a safe and effective treatment in chronic and severe forms of dry eye particularly due to mucus deficiency. Key Words: Dry eye, Goblet cell, Microvilli, Rebamipide, Tear film
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Indian Journal of Clinical and Experimental Ophthalmology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
